Ten-year changes in colorectal cancer screening in Switzerland: The Swiss Health Interview Survey 2007, 2012 and 2017.

Détails

Ressource 1Télécharger: 1-s2.0-S221133552200122X-main (1).pdf (635.96 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_95929955877C
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Ten-year changes in colorectal cancer screening in Switzerland: The Swiss Health Interview Survey 2007, 2012 and 2017.
Périodique
Preventive medicine reports
Auteur⸱e⸱s
Schneider R., Syrogiannouli L., Bissig S., Scharf T., Bulliard J.L., Ducros C., Del Giovane C., Tal K., Zwahlen M., Selby K., Auer R.
ISSN
2211-3355 (Print)
ISSN-L
2211-3355
Statut éditorial
Publié
Date de publication
06/2022
Peer-reviewed
Oui
Volume
27
Pages
101815
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Recent recommendations for colorectal cancer (CRC) screening suggest fecal occult blood test (FOBT) or colonoscopy. Since 2013, mandatory health insurance in Switzerland reimburse CRC screening. We set out to determine if CRC testing rate and type of CRC screening changed in Switzerland from 2007 to 2017 and between the three main language regions. We extracted data on 50-75-year-olds from the Swiss Health Interview Survey (SHIS) 2007, 2012 and 2017 to determine rates of self-reported testing with FOBT within last 2 years and colonoscopy within last 10 years. We estimated prevalence ratio (PR) in multivariate-adjusted logistic regression models and compared rates in German-, French- and Italian-speaking regions, adjusting for sociodemographic, self-rated health and insurance variables. Overall testing rates (FOBT or colonoscopy) increased in all regions from 2007 to 2017 (German-speaking 33.6% to 48.3%; French-speaking 30.8% to 48.8%; Italian-speaking 37.9% to 46.8%), mainly because of an increase in colonoscopy rate for screening reasons (p < 0.001 in all regions). Rates of FOBT testing fell significantly in the German-speaking region (11.9% to 4.4%, p < 0.001), but not in the Italian- (13.9% to 8.5%, p = 0.052) and French-speaking regions (7.6% to 7.4%, p = 0.138). Overall CRC testing rate rose from 33.2% in 2007 to 48.4% in 2017, mainly because of an increase of colonoscopy rate for screening reasons. Coverage remains below the 65% target of European guidelines. Organized screening programs encouraging FOBT screening could contribute to further increasing the CRC testing rate.
Mots-clé
article, cancer screening, colonoscopy, colorectal cancer, controlled study, demography, human, insurance, interview, language, occult blood, practice guideline, prevalence ratio, speech, Switzerland, CHF, Swiss franc, CRC, Colorectal Cancer, Colonoscopy, Colorectal cancer screening, FIT, fecal immunochemical Test, FOBT, Fecal occult blood test, Fecal occult blood test (FOBT), HDHP, High deductible health plan, HMO, Health Maintenance Organisation, LDHP, Low deductible health plan, SFSO, Swiss Federal Statistics Office, SHIS, Swiss Health Interview Survey
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/05/2022 15:04
Dernière modification de la notice
23/11/2022 6:50
Données d'usage